Clinical Consultations™: Focusing on Fabry Disease in Females: Individualizing Diagnostic and Counseling Plans to Improve Long-Term Outcomes
July 7, 2022
July 7, 2023
Scroll to the Bottom of this Information to Begin this Course
This activity is provided by Physicians’ Education Resource®, LLC.
This activity is supported by an educational grant from Chiesi USA.
- Physicians — maximum of 0.75 AMA PRA Category 1 Credit(s)™
- Nurses — 0.75 Contact Hours
All other healthcare professionals completing this course will be issued a statement of participation.
This educational activity is directed toward geneticists, genetic counselors, pediatricians, endocrinologists, cardiologists, nephrologists, primary care physicians, nurses, nurse practitioners, physician assistants, and other health care professionals who are involved in the care of patients with Fabry disease.
This Clinical Consultations™: Focusing on Fabry Disease in Females – Individualizing Diagnostic and Counseling Plans to Improve Long-Term Outcomes is a video-based program in which 2 experts use a case-based approach to discuss the treatment and management of women with Fabry disease. In this activity, the faculty focus on the diagnosis, management, and monitoring of patients with Fabry disease. This engaging format is designed to help clinicians identify best practices in the diagnosis and management of Fabry disease and to improve outcomes for their patients with this disease.
Upon successful completion of this activity, you should be better prepared to:
- Review the range of clinical presentations of Fabry Disease in female patients
- Apply evidence-based guidelines for screening and diagnosis of Fabry Disease to female patients
- Assess currently available therapies for female patients with Fabry Disease
- Integrate new and emerging therapies into management plans for female patients with Fabry Disease
Dawn A. Laney, MS, CGC
Director, Genetic Clinic Trials Center
Department of Human Genetics
Eric Wallace, MD, FASN
Associate Professor of Medicine
Department of Medicine, Division of Nephrology
Director of Telemedicine
Co-Director of Home Dialysis Program
The University of Alabama at Birmingham (UAB)
Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians’ Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 0.75 Contact Hours.
Faculty, Staff, and Planners’ Disclosures
The staff of Physicians’ Education Resource®, LLC have no relevant financial relationships with ineligible entities.
- Dawn A. Laney, MS, CGC
- Grant/Research Support: Sanofi-Genzyme, Amicus Therapeutics
- Consultant: Spark Therapeutics, Sanofi-Genzyme, Amicus Therapeutics, Chiesi USA
- Stock/Shareholder: ThinkGenetic Foundation
- Eric Wallace, MD, FASN
- Grant/Research Support: Idorsia, Sanofi Genzyme, 4D Molecular Therapeutics, Protalix BioTherapeutics, Chiesi USA, Amicus Therapeutics
- Consultant: Idorsia, Sanofi Genzyme, 4D Molecular Therapeutics, Protalix BioTherapeutics, Chiesi USA, Amicus Therapeutics
PER® mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.
Instructions for Participation and Credit
- Complete the activity (including pre- and post-activity assessments).
- Answer the evaluation questions.
- Request credit using the drop-down menu.
Course Viewing Requirements
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above
Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above
Off-Label Disclosure and Disclaimer
This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a healthcare professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER®; or any company that provided commercial support for this activity.